Obsidian Therapeutics

Obsidian Therapeutics is using its proprietary cytoDRiVE® platform to harness the power of proteins to engineer precision medicines.

Elizabeth Weisman

Senior Research Associate at Obsidian Therapeutics

Alfredo Rojas

Sr. Associate Scientist at Obsidian Therapeutics

Todd Hawley

Director Regulatory Affairs CMC at Obsidian Therapeutics

Sean Smith

Senior Scientist at Obsidian Therapeutics

Meghan Walsh

Principal Scientist at Obsidian Therapeutics

Shreyas Dahotre

Senior Scientist, Analytical Development at Obsidian Therapeutics

Lee Giguere

Chief Legal Officer at Obsidian Therapeutics

J Isaac Godfroy

Principal Scientist, Process Development at Obsidian Therapeutics

Eric Gennell

Obsidian Therapeutics

Dexue Sun

Senior Scientist at Obsidian Therapeutics

Rachel Burga

Principal Scientist at Obsidian Therapeutics

Parameswaran Hari

Chief Development Officer (CDO) at Obsidian Therapeutics

Maria Fardis

Venture Partner at Obsidian Therapeutics

Brian O'Rourke

Principal Scientist, Process Development at Obsidian Therapeutics

Gwen Wilmes

Vice President, Analytical Development at Obsidian Therapeutics

Tyler Humpton

Senior Associate Scientist at Obsidian Therapeutics

Carmela Passaro

Senior Scientist at Obsidian Therapeutics

Michael Gilman

Chief Executive Officer at Obsidian Therapeutics

Nic Betts

Obsidian Therapeutics

Paul Wotton

Board Member at Obsidian Therapeutics